6TIK image
Entry Detail
PDB ID:
6TIK
EMDB ID:
Title:
Hepatitis B virus core shell--virus-like particle with NadA epitope
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2019-11-22
Release Date:
2020-04-29
Method Details:
Experimental Method:
Resolution:
3.40 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Capsid protein,Putative adhesin/invasin,Capsid protein,Factor H-binding protein
Chain IDs:A (auth: C), B (auth: D), C (auth: B), D (auth: A)
Chain Length:589
Number of Molecules:4
Biological Source:Hepatitis B virus, Neisseria meningitidis
Ligand Molecules
Primary Citation
An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.
Vaccine 38 3201 3209 (2020)
PMID: 32178907 DOI: 10.1016/j.vaccine.2020.03.001

Abstact

Neisseria meningitidis is the causative agent of meningococcal meningitis and sepsis and remains a significant public health problem in many countries. Efforts to develop a comprehensive vaccine against serogroup B meningococci have focused on the use of surface-exposed outer membrane proteins. Here we report the use of virus-like particles derived from the core protein of Hepatitis B Virus, HBc, to incorporate antigen domains derived from Factor H binding protein (FHbp) and the adhesin NadA. The extracellular domain of NadA was inserted into the major immunodominant region of HBc, and the C-terminal domain of FHbp at the C-terminus (CFHbp), creating a single polypeptide chain 3.7-fold larger than native HBc. Remarkably, cryoelectron microscopy revealed that the construct formed assemblies that were able to incorporate both antigens with minimal structural changes to native HBc. Electron density was weak for NadA and absent for CFHbp, partly attributable to domain flexibility. Following immunization of mice, three HBc fusions (CFHbp or NadA alone, NadA + CFHbp) were able to induce production of IgG1, IgG2a and IgG2b antibodies reactive against their respective antigens at dilutions in excess of 1:18,000. However, only HBc fusions containing NadA elicited the production of antibodies with serum bactericidal activity. It is hypothesized that this improved immune response is attributable to the adoption of a more native-like folding of crucial conformational epitopes of NadA within the chimeric VLP. This work demonstrates that HBc can incorporate insertions of large antigen domains but that maintenance of their three-dimensional structure is likely to be critical in obtaining a protective response.

Legend

Protein

Chemical

Disease

Primary Citation of related structures